论文部分内容阅读
摘要目的验证非小细胞肺癌(NSCLC)病人术后FDG标记PET/CT检测的全身肿瘤代谢负荷(MTBWB)与病人总生存率(OS)有关这一假说。材料与方法本研究经机构伦理
Abstract Objective To verify the hypothesis that systemic metabolic load (MTBWB) measured by FDG-labeled PET / CT in patients with non-small cell lung cancer (NSCLC) and overall survival (OS) Materials and Methods This study is organized by Institutional Ethics